Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > Our Work > All Publications > 2011


Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.

Find an article or report by keywords:

Find an article or report or see all by area, author, or year:


Acting on the Lessons of SARS: What Remains To Be Done?

Eric S. Toner, Jennifer B. Nuzzo
Date posted:
June 07, 2011
Publication type:

Biosecur Bioterror 2011;9(2):169-174

Mary Ann Liebert, Inc.
Open access
See also:

Full article available on publisher's site: HTML • PDF


On November 16, 2002, a man was admitted with a diagnosis of atypical pneumonia to People’s Hospital #1 in Foshan City, Guangdong Province, People’s Republic of China. Although it was not recognized at the time, he was the earliest known case of a new human infectious disease, Severe Acute Respiratory Syndrome, or SARS. Within 4 months SARS was global, eventually infecting 8,098 people in 29 countries on 6 continents and killing 774 of them.1 Even more concerning than these numbers is the fact that in many locations most of the victims were infected in hospitals2 and 21% of the victims were healthcare workers.3 At the time, SARS caused great alarm in the public health and medical preparedness communities. National and international guidance was issued, many health departments and hospitals created SARS plans, personal protective equipment was purchased, and healthcare workers were trained in respiratory precautions. In the months following the SARS pandemic, a number of conferences were held and reports issued on lessons learned from SARS. Now, from the vantage point of 8 years’ distance, what did we really learn? What are the remaining unanswered questions? What remains to be done?



Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.